insulin analogs

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instance_of gptkb:Company
gptkbp:appointed_by injection
gptkbp:approves gptkb:FDA
gptkbp:are oral medications
cures for diabetes
gptkbp:benefits gptkb:regular_insulin
gptkbp:can_be_used_with gptkb:product
lifestyle changes
continuous glucose monitors
oral hypoglycemics
gptkbp:caused_by allergic reactions
gptkbp:developed_by gptkb:Company
pharmaceutical companies
late 20th century
gptkbp:has_impact_on blood glucose levels
gptkbp:has_variants peak times
duration of action
onset times
https://www.w3.org/2000/01/rdf-schema#label insulin analogs
gptkbp:improves glycemic control
gptkbp:includes gptkb:insulin_lispro
gptkb:insulin_aspart
gptkb:insulin_degludec
gptkb:insulin_detemir
gptkb:insulin_glulisine
gptkbp:influence insulin sensitivity
gptkbp:is_available_in gptkb:tablet
gptkb:railway_station
various formulations
vial
various strengths
gptkbp:is_compared_to gptkb:regular_insulin
gptkbp:is_considered essential medicines
modern treatment options
gptkbp:is_evaluated_by clinical trials
efficacy and safety
gptkbp:is_implemented_in hospital settings
gptkbp:is_monitored_by blood sugar levels
gptkbp:is_part_of insulin therapy
personalized medicine approaches
diabetes care plans
gptkbp:is_subject_to gptkb:municipality
regulatory approval
insurance coverage
gptkbp:is_used_by diabetes patients
gptkbp:is_used_for diabetes management
intensive insulin therapy
manage postprandial glucose spikes
prevent ketoacidosis
gptkbp:is_used_in gestational diabetes
gptkbp:is_used_to achieve target A1 C levels
gptkbp:recommendation gptkb:hospital
gptkbp:requires prescription
gptkbp:risk_factor diabetes complications
gptkbp:side_effect weight gain
hypoglycemia
gptkbp:storage room temperature
gptkbp:type synthetic insulin
gptkbp:used_in type 2 diabetes
type 1 diabetes
gptkbp:bfsParent gptkb:Humalog
gptkbp:bfsLayer 4